Role of Nitric Oxide in the Change of 5-Hydroxytryptamine Synthesis in the Intestine by a Consecutive Administration of Methotrexate to Rats.


Journal

Pharmacology
ISSN: 1423-0313
Titre abrégé: Pharmacology
Pays: Switzerland
ID NLM: 0152016

Informations de publication

Date de publication:
2020
Historique:
received: 27 04 2020
accepted: 25 05 2020
pubmed: 23 7 2020
medline: 18 3 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

This study aimed to investigate whether the consecutive administration of methotrexate affects 5-hydroxytryptamine (5-HT) synthesis in the rat small intestine. Rats received methotrexate at a dose of 12.5 mg/kg intraperitoneally on 4 consecutive days. NG-nitro-L-arginine methyl ester (L-NAME) was given subcutaneously to inhibit nitric oxide (NO) synthase. Methotrexate moderately altered 5-HT synthesis, whereas the combined administration of methotrexate and L-NAME significantly changed 5-HT synthesis in the rat ileal tissue. These results suggest that endogenous NO has an antagonistic role in the induction of 5-HT synthesis in rats following the consecutive administration of methotrexate.

Identifiants

pubmed: 32694256
pii: 000508973
doi: 10.1159/000508973
doi:

Substances chimiques

Enzyme Inhibitors 0
RNA, Messenger 0
Tachykinins 0
Nitric Oxide 31C4KY9ESH
Serotonin 333DO1RDJY
Substance P 33507-63-0
Nitric Oxide Synthase EC 1.14.13.39
Tryptophan Hydroxylase EC 1.14.16.4
NG-Nitroarginine Methyl Ester V55S2QJN2X
Methotrexate YL5FZ2Y5U1

Types de publication

News

Langues

eng

Sous-ensembles de citation

IM

Pagination

723-728

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Takuji Machida (T)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan, tmachida@hoku-iryo-u.ac.jp.

Akari Inotani (A)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Saki Shiga (S)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Shuto Kon (S)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Takumi Yanada (T)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Hiroya Kobayashi (H)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Naoya Hamaue (N)

Department of Molecular Biosciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Masahiko Hirafuji (M)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Kenji Iizuka (K)

Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH